Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vandetanib in Relapsed Multiple Myeloma
NCT00047788Phase 2Completed
- Sponsor
- Sanofi
- Start
- Oct 2002
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of vandetanib in multiple myeloma (MM), sponsored by Sanofi. Started Oct 2002; status: completed.
02
Drugs
vandetanib
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT00047788.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00047788.